KPG-810

N/A

Report date: 2025/01/26 17:42:17
NME

Base Information

Drug NameKPG-810
Drug Alias NameKPG-810
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases modulatorsCereblon modulators
TargetsUbiquitin-protein ligasesCereblon
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKangpu Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A